Is Enliven Therapeutics, Inc. technically bullish or bearish?

Nov 02 2025 11:20 AM IST
share
Share Via
As of October 31, 2025, Enliven Therapeutics, Inc. shows a bullish trend supported by strong indicators, despite some caution from mildly bearish KST signals and a longer-term underperformance compared to the S&P 500.
As of 31 October 2025, the technical trend for Enliven Therapeutics, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish. Daily moving averages also indicate a bullish trend. However, the KST shows a mildly bearish signal on both weekly and monthly time frames, which suggests some caution.

In terms of performance, the stock has outperformed the S&P 500 significantly over the past week (13.63% vs. 0.71%) and month (18.13% vs. 1.92%), but has underperformed over the longer term, with a 1-year return of -15.91% compared to the S&P 500's 19.89%. Overall, the technical indicators suggest a bullish outlook, albeit with some mixed signals in the longer-term trends.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News